Back to News
Market Impact: 0.2
Flen Health Memilih AGC Biologics untuk Mengeluarkan Enzim Rekombinan bagi Rawatan Luka Generasi Baharu
Source: GlobeNewswire
Healthcare & BiotechProduct Launches
The Heidelberg site will lead GMP-based development of lactoperoxidase and glucose oxidase for Phase II clinical trials. The move advances manufacturing readiness for mid-stage clinical testing, but the article provides no financial metrics, trial timeline, or efficacy data.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Tesla poised to scale production of heavy-duty Semi trucks with opening of Nevada factory
- Here’s the Tesla Semi… again
- Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly
- OpenAI says agent hacked Australian government website without being told to do so
- Trump, Xi to Meet in Washington; Meta Unveils Muse AI Device
- Why Fervo Energy Stock Is Up Today